ZA939229B - Triazoloquinazolines for the treatment of central nervous disorders - Google Patents
Triazoloquinazolines for the treatment of central nervous disordersInfo
- Publication number
- ZA939229B ZA939229B ZA939229A ZA939229A ZA939229B ZA 939229 B ZA939229 B ZA 939229B ZA 939229 A ZA939229 A ZA 939229A ZA 939229 A ZA939229 A ZA 939229A ZA 939229 B ZA939229 B ZA 939229B
- Authority
- ZA
- South Africa
- Prior art keywords
- triazoloquinazolines
- central nervous
- pct
- treatment
- nervous disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4241564A DE4241564A1 (de) | 1992-12-10 | 1992-12-10 | Triazolochinazoline zur Behandlung zentralnervöser Erkrankungen |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA939229B true ZA939229B (en) | 1995-06-09 |
Family
ID=6474850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA939229A ZA939229B (en) | 1992-12-10 | 1993-12-09 | Triazoloquinazolines for the treatment of central nervous disorders |
Country Status (13)
Country | Link |
---|---|
US (1) | US5612344A (fr) |
EP (1) | EP0673249B1 (fr) |
JP (1) | JPH08504418A (fr) |
KR (1) | KR950703962A (fr) |
AT (1) | ATE177637T1 (fr) |
AU (1) | AU673225B2 (fr) |
CA (1) | CA2151241A1 (fr) |
CZ (1) | CZ144895A3 (fr) |
DE (2) | DE4241564A1 (fr) |
MX (1) | MX9307837A (fr) |
NZ (1) | NZ258887A (fr) |
WO (1) | WO1994013294A1 (fr) |
ZA (1) | ZA939229B (fr) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH490362A (de) * | 1967-04-03 | 1970-05-15 | Upjohn Co | Verfahren zur Herstellung von 20-Ketosteroidverbindungen |
DE3146599A1 (de) * | 1981-11-25 | 1983-07-07 | Basf Ag, 6700 Ludwigshafen | Neue triazolochinazoline, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen |
US4713383A (en) * | 1984-10-01 | 1987-12-15 | Ciba-Geigy Corporation | Triazoloquinazoline compounds, and their methods of preparation, pharmaceutical compositions, and uses |
EP0181282A1 (fr) * | 1984-10-01 | 1986-05-14 | Ciba-Geigy Ag | Composés de la triazolo-quinazoline |
US5153196A (en) * | 1991-06-05 | 1992-10-06 | Eli Lilly And Company | Excitatory amino acid receptor antagonists and methods for the use thereof |
-
1992
- 1992-12-10 DE DE4241564A patent/DE4241564A1/de not_active Withdrawn
-
1993
- 1993-12-06 AU AU56965/94A patent/AU673225B2/en not_active Ceased
- 1993-12-06 AT AT94902687T patent/ATE177637T1/de not_active IP Right Cessation
- 1993-12-06 CZ CZ951448A patent/CZ144895A3/cs unknown
- 1993-12-06 EP EP94902687A patent/EP0673249B1/fr not_active Expired - Lifetime
- 1993-12-06 DE DE59309469T patent/DE59309469D1/de not_active Expired - Fee Related
- 1993-12-06 US US08/433,509 patent/US5612344A/en not_active Expired - Fee Related
- 1993-12-06 KR KR1019950702355A patent/KR950703962A/ko not_active Application Discontinuation
- 1993-12-06 JP JP6513758A patent/JPH08504418A/ja active Pending
- 1993-12-06 NZ NZ258887A patent/NZ258887A/en unknown
- 1993-12-06 CA CA002151241A patent/CA2151241A1/fr not_active Abandoned
- 1993-12-06 WO PCT/EP1993/003424 patent/WO1994013294A1/fr active IP Right Grant
- 1993-12-09 ZA ZA939229A patent/ZA939229B/xx unknown
- 1993-12-10 MX MX9307837A patent/MX9307837A/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU673225B2 (en) | 1996-10-31 |
CZ144895A3 (en) | 1995-12-13 |
ATE177637T1 (de) | 1999-04-15 |
EP0673249B1 (fr) | 1999-03-17 |
DE4241564A1 (de) | 1994-06-16 |
JPH08504418A (ja) | 1996-05-14 |
US5612344A (en) | 1997-03-18 |
AU5696594A (en) | 1994-07-04 |
DE59309469D1 (de) | 1999-04-22 |
EP0673249A1 (fr) | 1995-09-27 |
CA2151241A1 (fr) | 1994-06-23 |
KR950703962A (ko) | 1995-11-17 |
NZ258887A (en) | 1997-06-24 |
WO1994013294A1 (fr) | 1994-06-23 |
MX9307837A (es) | 1994-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG55184A1 (en) | New imidazopyridines | |
ZA934374B (en) | N-substituted azabicycloheptane derivatives the preparation and use thereof | |
GB9418912D0 (en) | Pharmaceutically active compounds | |
TW238305B (fr) | ||
ZA949593B (en) | N-substituted azabicycloheptane derivatives their preparation and use | |
TW261614B (fr) | ||
TW251283B (fr) | ||
ZA939229B (en) | Triazoloquinazolines for the treatment of central nervous disorders | |
DE59409813D1 (de) | Imidazolochinoxalinone zur behandlung zentralnervöser erkrankungen | |
DK0646113T3 (fr) | ||
GR3023147T3 (en) | New triazoloquinazolines, their production and their use. | |
TW252043B (fr) | ||
DK0729469T3 (da) | Imidazo[1,5-a]quinoliner til behandling af angst og søvnforstyrrelser | |
GB9223445D0 (en) | Therapeutic agents |